BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 28461309)

  • 1. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
    Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analyses of
    Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
    J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.
    Warrilow AGS; Parker JE; Price CL; Garvey EP; Hoekstra WJ; Schotzinger RJ; Wiederhold NP; Nes WD; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
    Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens.
    Warrilow AGS; Parker JE; Price CL; Rolley NJ; Nes WD; Kelly DE; Kelly SL
    Int J Antimicrob Agents; 2019 Oct; 54(4):449-455. PubMed ID: 31310805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs.
    Hargrove TY; Wawrzak Z; Lamb DC; Guengerich FP; Lepesheva GI
    J Biol Chem; 2015 Sep; 290(39):23916-34. PubMed ID: 26269599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.
    Xiao L; Madison V; Chau AS; Loebenberg D; Palermo RE; McNicholas PM
    Antimicrob Agents Chemother; 2004 Feb; 48(2):568-74. PubMed ID: 14742211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus.
    Ding Z; Ni T; Xie F; Hao Y; Yu S; Chai X; Jin Y; Wang T; Jiang Y; Zhang D
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126951. PubMed ID: 31926784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.
    Warrilow AG; Hull CM; Parker JE; Garvey EP; Hoekstra WJ; Moore WR; Schotzinger RJ; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7121-7. PubMed ID: 25224009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
    Friggeri L; Hargrove TY; Wawrzak Z; Blobaum AL; Rachakonda G; Lindsley CW; Villalta F; Nes WD; Botta M; Guengerich FP; Lepesheva GI
    J Med Chem; 2018 Jul; 61(13):5679-5691. PubMed ID: 29894182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.
    Warrilow AG; Parker JE; Price CL; Nes WD; Garvey EP; Hoekstra WJ; Schotzinger RJ; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4530-8. PubMed ID: 27161631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance.
    Edlind TD; Henry KW; Metera KA; Katiyar SK
    Med Mycol; 2001 Jun; 39(3):299-302. PubMed ID: 11446535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Wilson RK; Monk BC; Tyndall JD
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4982-9. PubMed ID: 26055382
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Colley T; Alanio A; Kelly SL; Sehra G; Kizawa Y; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Anderson-Dring L; Nakaoki T; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; Cooke M; Bretagne S; King-Underwood J; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
    Zhao S; Wei P; Wu M; Zhang X; Zhao L; Jiang X; Hao C; Su X; Zhao D; Cheng M
    Bioorg Med Chem; 2018 Jul; 26(12):3242-3253. PubMed ID: 29748145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii.
    Lockhart SR; Fothergill AW; Iqbal N; Bolden CB; Grossman NT; Garvey EP; Brand SR; Hoekstra WJ; Schotzinger RJ; Ottinger E; Patterson TF; Wiederhold NP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2528-31. PubMed ID: 26787697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
    Warrilow AG; Price CL; Parker JE; Rolley NJ; Smyrniotis CJ; Hughes DD; Thoss V; Nes WD; Kelly DE; Holman TR; Kelly SL
    Sci Rep; 2016 Jun; 6():27690. PubMed ID: 27291783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.